|
Importantly however this latest agreement in principle allows for the existing bond debt to be split in two instruments, with $ 50 million converted into a 2nd lien mortgage instrument, whilst the remaining $ 60 million will remain as an unsecured loan. This unsecured note will be callable by the Company into $ 10 million of equity in a future stock issue. The 2nd lien instrument will also include $ 30 million of converted senior bank debt. The agreement is subject to formal approval by the banks' credit committees and a bondholder meeting. In anticipation of a definitive agreement, the banks have granted a waiver in respect of the current minimum cash covenant and loan-to-value covenant until the end of October. Furthermore, in anticipation of consummation of the agreement, the trustee of the bond loan and the banks' steering committee have agreed to give the Company a grace period for payment of interest until the end of October. Deferred interest for the bank and bond loan will be handled according to the new financial plan set out above. ABG Sundal Collier has acted as advisors to the Company, Alix Partners as advisors to the banks and AMA Capital Partners as advisors to the bondholders. The Company will announce more details regarding the refinancing and distribute summons to a bondholders meeting in due course. Eitzen Chemical ASA press release |